Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer.
Kusama H, Kittaka N, Soma A, Taniguchi A, Kanaoka H, Nakajima S, Oyama Y, Seto Y, Okuno J, Watanabe N, Matsui S, Nishio M, Fujisawa F, Honma K, Tamaki Y, Nakayama T.
Kusama H, et al. Among authors: kanaoka h.
Breast Cancer. 2023 Nov;30(6):1085-1093. doi: 10.1007/s12282-023-01504-y. Epub 2023 Oct 2.
Breast Cancer. 2023.
PMID: 37782377